| Transforming growth factor-β signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain PT Ronaldson, KM DeMarco, L Sanchez-Covarrubias, CM Solinsky, ... Journal of Cerebral Blood Flow & Metabolism 29 (6), 1084-1098, 2009 | 169 | 2009 |
| Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders RW Irwin, CM Solinsky, RD Brinton Frontiers in cellular neuroscience 8, 203, 2014 | 83 | 2014 |
| Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer’s disease RW Irwin, CM Solinsky, CM Loya, FG Salituro, KE Rodgers, G Bauer, ... PloS one 10 (6), e0128313, 2015 | 53 | 2015 |
| Development of a unified clinical trial database for Alzheimer's disease J Neville, S Kopko, S Broadbent, E Avilés, R Stafford, CM Solinsky, ... Alzheimer's & Dementia 11 (10), 1212-1221, 2015 | 42 | 2015 |
| Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: a single and multiple ascending dose phase 1b/2a clinical … GD Hernandez, CM Solinsky, WJ Mack, N Kono, KE Rodgers, CY Wu, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 6 (1 …, 2020 | 30 | 2020 |
| Medial prefrontal cortex lesions in mice do not impair effort-based decision making C Solinsky, BP Kirby Neuropharmacology 65, 223-231, 2013 | 17 | 2013 |
| [P3–167]: DEVELOPMENT OF AN IPSC‐BASED BIOMARKER STRATEGY TO IDENTIFY NEUROREGENERATIVE RESPONDERS TO ALLOPREGNANOLONE CM Solinsky, JA Park, HC Chui, M Blurton‐Jones, JK Ichida, ... Alzheimer's & Dementia 13 (7S_Part_20), P998-P998, 2017 | 1 | 2017 |
| P3‐039: Early‐stage development of ips‐based biomarkers to identify patient population with a regenerative profile responsive to allopregnanolone CM Solinsky, MK Desai, J Yao, V Hennes, H Chang Chui, JK Ichida, ... Alzheimer's & Dementia 11 (7S_Part_13), P633-P634, 2015 | 1 | 2015 |
| P3‐032: COMBINING SEX, APOE GENOTYPE, AND MITOCHONDRIAL GENETIC VARIANCE AS PREDICTIVE RESPONDER IDENTIFIER TO REGENERATIVE THERAPEUTIC ALLOPREGNANOLONE FOR ALZHEIMER'S DISEASE Y Wang, CM Solinsky, GD Hernandez, LS Schneider, RD Brinton Alzheimer's & Dementia 15, P938-P938, 2019 | | 2019 |
| P1‐018: MITOCHONDRIAL HAPLOGROUP IN COMBINATION WITH APOE GENOTYPE AS POTENTIAL PREDICTIVE BIOMARKER TO IDENTIFY RESPONDERS TO REGENERATIVE THERAPEUTIC ALLOPREGNANOLONE FOR … Y Wang, CM Solinsky, GD Hernandez, LS Schneider, RD Brinton Alzheimer's & Dementia 14 (7S_Part_4), P271-P272, 2018 | | 2018 |
| [P4–020]: CLINICAL TRIAL RECRUITMENT FRAMEWORK FOR EARLY ALZHEIMER's DISEASE RW Irwin, G Hernandez, CM Solinsky, CM Lopez, N Kono, WJ Mack, ... Alzheimer's & Dementia, P1262-P1262, 2017 | | 2017 |
| P1‐072: Comparative Pharmacokinetic Assessment of Allopregnanolone to Develop a Regenerative Therapeutic for Mild Cognitive Impairment and Early Alzheimer’s Disease RW Irwin, CM Solinsky, KE Rodgers, G Bauer, MA Rogawski, RD Brinton Alzheimer's & Dementia 12, P430-P430, 2016 | | 2016 |
| P3‐138: Development of IPSC‐Based Biomarkers to Identify the Patient Population Responsive to Allopregnanolone CM Solinsky, V Hennes, M Blurton-Jones, JA Park, HC Chui, JK Ichida, ... Alzheimer's & Dementia 12, P871-P871, 2016 | | 2016 |
| P1‐303: Allopregnanolone chronic exposure using regenerative treatment regimen: Preclinical ind enabling toxicology indicating safety RW Irwin, K Kim, CE Green, CM Solinsky, G Bauer, MA Rogawski, ... Alzheimer's & Dementia 11 (7S_Part_10), P472-P473, 2015 | | 2015 |
| Transforming growth factor-beta (TGF-beta) signaling is involved in the regulation of blood-brain barrier (BBB) functional integrity during peripheral inflammatory pain PT Ronaldson, KM Demarco, L Sanchez-Covarrubias, CM Solinsky, ... JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 29, S484-S484, 2009 | | 2009 |
